Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Core Scientific (CORZ) Equity Average: 2021-2025

Historic Equity Average for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to -$1.1 billion.

  • Core Scientific's Equity Average fell 19.86% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 19.86%. This contributed to the annual value of -$708.6 million for FY2024, which is 40.83% down from last year.
  • Latest data reveals that Core Scientific reported Equity Average of -$1.1 billion as of Q3 2025, which was down 75.95% from -$623.1 million recorded in Q2 2025.
  • Core Scientific's 5-year Equity Average high stood at $1.2 billion for Q1 2022, and its period low was -$1.1 billion during Q3 2025.
  • Over the past 3 years, Core Scientific's median Equity Average value was -$507.8 million (recorded in 2023), while the average stood at -$617.1 million.
  • Per our database at Business Quant, Core Scientific's Equity Average soared by 9,331.42% in 2022 and then tumbled by 265.72% in 2023.
  • Core Scientific's Equity Average (Quarterly) stood at $645.1 million in 2021, then tumbled by 126.07% to -$168.2 million in 2022, then tumbled by 202.00% to -$507.8 million in 2023, then plummeted by 52.57% to -$774.8 million in 2024, then dropped by 19.86% to -$1.1 billion in 2025.
  • Its Equity Average was -$1.1 billion in Q3 2025, compared to -$623.1 million in Q2 2025 and -$500.8 million in Q1 2025.